Sophia Genetics raised €67M in a Series D+ round in Jan 2019. The company is based in Saint-Sulpice, Switzerland. Investors in the round: Balderton Capital. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
